The New York Times has reported that executives at Walgreens Boots Alliance asked consultants to remove findings from an internal report that included complaints from its employees. For a better way of making sure information isn’t hidden from the board, look towards this technology darling.
The healthcare industry has been a fountain of dealmaking lately. Companies wanting to make acquisitions or sell businesses this year should learn from the experts.
The efforts of President Donald Trump’s administration to force healthcare providers such as hospitals and drug makers to disclose pricing isn’t going down without a fight.
The potential uses of data are exploding. But so are the regulations to keep that in check.
Two IPO experts share advice for private equity leaders ahead of going public. They also discuss popular types of IPOs, the trend of direct listings, and why super shares are bad for companies in the long term.
One of the biggest changes to healthcare for years has been the shift from fee-for-service to reimbursements based on the quality of care. How has that shift been going?
There were 1,900 deals in the space last year, according to Connecticut-based publisher Irving Levin Associates in its 2019 report “Seniors Housing & Health Care M&A in the 21st Century.” For buyers, the cool kids on the block were long-term care facilities and physician medical groups, which led the charge for deal-making and consolidation.
Private equity is on the prowl for good deals in the healthcare space right now. There’s a lot of competition and money searching for an investment opportunity. Sometimes, those opportunities involve public companies looking to go private.
Despite headwinds that threatened to throw off healthcare deals, mergers and acquisitions were active in 2019. Even big deals weren’t off the table, despite the uncertainty created by a federal judge’s 2018 decision that the Affordable Care Act was unconstitutional. In fact, some of the biggest deals of early 2019 were in the healthcare space.